Quick Answer
Bioventus Inc. reported Net Income Loss of $22.73 million for the year ending 2025.
- Bioventus Inc. showed an increase of +162.9% in Net Income Loss from 2024 to 2025.
- This data is from Bioventus Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Bioventus Inc.'s Net Income Loss has grown by 231.8%.
- Historical annual values: Fiscal year 2025: $22.73 million | Fiscal year 2024: -$36.13 million | Fiscal year 2023: -$156.23 million | Fiscal year 2022: -$158.70 million | Fiscal year 2021: $19.38 million | Fiscal year 2020: $16.41 million | Fiscal year 2019: $6.85 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: